Marc Gruninger
Marc Gruninger has made 1 open-market purchase worth $10k since Oct 29, 2026, in 1 company. The latest: $10k of VRXA, filed Oct 29, 2026, scored 34 out of 100.
Director, Veraxa Biotech AG - Post de-SPAC
Follow Marc Gruninger, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 29 Form 4 (opens sec.gov) |
VRXAVeraxa Biotech AG - Post de-SPAC · DirectorDirector · Near 52-week low · Penny stock: hard to trade | New position | 34 | $10k 10,000 at $1.00 |
— | — |
Questions
What stock has Marc Gruninger bought?
VRXA (Veraxa Biotech AG - Post de-SPAC), all on the open market and reported on SEC Form 4.
When did Marc Gruninger last buy?
Oct 29, 2026: 10,000 shares of VRXA at $1.00, $10k in all (Form 4 (opens sec.gov)).
Has Marc Gruninger filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Marc Gruninger a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 29, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer